Literature DB >> 24694638

Epigenetics, opium, and cancer.

Ata Mahmoodpoor1, Samad E J Golzari2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24694638     DOI： 10.1016/S1470-2045(14)70077-4

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

1.  Opium Use and Risk of Pancreatic Cancer: A Prospective Cohort Study.

Authors:  Shirin Moossavi; Mehdi Mohamadnejad; Akram Pourshams; Hossein Poustchi; Farhad Islami; Maryam Sharafkhah; Babak Mirminachi; Siavosh Nasseri-Moghaddam; Shahryar Semnani; Ramin Shakeri; Arash Etemadi; Shahin Merat; Masoud Khoshnia; Sanford M Dawsey; Paul D Pharoah; Paul Brennan; Christian C Abnet; Paolo Boffetta; Farin Kamangar; Reza Malekzadeh
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-12-20       Impact factor: 4.254

Review 2.  Opium and bladder cancer: A systematic review and meta-analysis of the odds ratios for opium use and the risk of bladder cancer.

Authors:  Mahdi Afshari; Ghasem Janbabaei; Mohammad Amin Bahrami; Mahmood Moosazadeh
Journal:  PLoS One       Date:  2017-06-06       Impact factor: 3.240

3.  Evaluation of blood lead level in methamphetamine users in Tehran.

Authors:  Babak Mostafazadeh; Shahin Shadnia; Mohammad Ali Tavakkoli; Hamid Reza Khoddami Vishteh
Journal:  Subst Abuse Treat Prev Policy       Date:  2017-02-22

4.  Overexpression of Adiponectin Receptors in Opium Users with and without Cancer.

Authors:  Negar Firouzabadi; Maral Haghnegahdar; Bahman Khalvati; Ali Dehshahri; Ehsan Bahramali
Journal:  Clin Pharmacol       Date:  2020-06-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.